img

Global Antivenin Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antivenin Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Antivenin is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Antivenin market size was US$ 959.2 million in 2022 and is forecast to a readjusted size of US$ 1277.8 million by 2034 with a CAGR of 4.1% during the forecast period 2024-2034.
The United States market for Antivenin is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Antivenin is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Antivenin is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Antivenin include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts and Bharat Serums and Vaccines, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Antivenin, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Antivenin by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Antivenin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Antivenin market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL
By Type
Polyvalent
Monovalent
By Application
Hospitals and Clinics
Non-profit Institutions
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Antivenin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Antivenin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antivenin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Antivenin Definition
1.2 Market by Type
1.2.1 Global Antivenin Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Market Segment by Application
1.3.1 Global Antivenin Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antivenin Sales
2.1 Global Antivenin Revenue Estimates and Forecasts 2018-2034
2.2 Global Antivenin Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Antivenin Revenue by Region
2.3.1 Global Antivenin Revenue by Region (2018-2024)
2.3.2 Global Antivenin Revenue by Region (2024-2034)
2.4 Global Antivenin Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Antivenin Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Antivenin Sales Quantity by Region
2.6.1 Global Antivenin Sales Quantity by Region (2018-2024)
2.6.2 Global Antivenin Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Antivenin Sales Quantity by Manufacturers
3.1.1 Global Antivenin Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Antivenin Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Antivenin Sales in 2022
3.2 Global Antivenin Revenue by Manufacturers
3.2.1 Global Antivenin Revenue by Manufacturers (2018-2024)
3.2.2 Global Antivenin Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antivenin Revenue in 2022
3.3 Global Antivenin Sales Price by Manufacturers
3.4 Global Key Players of Antivenin, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antivenin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antivenin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antivenin, Product Offered and Application
3.8 Global Key Manufacturers of Antivenin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Antivenin Sales Quantity by Type
4.1.1 Global Antivenin Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Antivenin Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Antivenin Sales Quantity Market Share by Type (2018-2034)
4.2 Global Antivenin Revenue by Type
4.2.1 Global Antivenin Historical Revenue by Type (2018-2024)
4.2.2 Global Antivenin Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antivenin Revenue Market Share by Type (2018-2034)
4.3 Global Antivenin Price by Type
4.3.1 Global Antivenin Price by Type (2018-2024)
4.3.2 Global Antivenin Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antivenin Sales Quantity by Application
5.1.1 Global Antivenin Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Antivenin Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Antivenin Sales Quantity Market Share by Application (2018-2034)
5.2 Global Antivenin Revenue by Application
5.2.1 Global Antivenin Historical Revenue by Application (2018-2024)
5.2.2 Global Antivenin Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antivenin Revenue Market Share by Application (2018-2034)
5.3 Global Antivenin Price by Application
5.3.1 Global Antivenin Price by Application (2018-2024)
5.3.2 Global Antivenin Price Forecast by Application (2024-2034)
6 North America
6.1 North America Antivenin Sales by Company
6.1.1 North America Antivenin Revenue by Company (2018-2024)
6.1.2 North America Antivenin Sales Quantity by Company (2018-2024)
6.2 North America Antivenin Market Size by Type
6.2.1 North America Antivenin Sales Quantity by Type (2018-2034)
6.2.2 North America Antivenin Revenue by Type (2018-2034)
6.3 North America Antivenin Market Size by Application
6.3.1 North America Antivenin Sales Quantity by Application (2018-2034)
6.3.2 North America Antivenin Revenue by Application (2018-2034)
6.4 North America Antivenin Market Size by Country
6.4.1 North America Antivenin Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Antivenin Revenue by Country (2018-2034)
6.4.3 North America Antivenin Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Antivenin Sales by Company
7.1.1 Europe Antivenin Sales Quantity by Company (2018-2024)
7.1.2 Europe Antivenin Revenue by Company (2018-2024)
7.2 Europe Antivenin Market Size by Type
7.2.1 Europe Antivenin Sales Quantity by Type (2018-2034)
7.2.2 Europe Antivenin Revenue by Type (2018-2034)
7.3 Europe Antivenin Market Size by Application
7.3.1 Europe Antivenin Sales Quantity by Application (2018-2034)
7.3.2 Europe Antivenin Revenue by Application (2018-2034)
7.4 Europe Antivenin Market Size by Country
7.4.1 Europe Antivenin Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Antivenin Revenue by Country (2018-2034)
7.4.3 Europe Antivenin Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Antivenin Sales by Company
8.1.1 China Antivenin Sales Quantity by Company (2018-2024)
8.1.2 China Antivenin Revenue by Company (2018-2024)
8.2 China Antivenin Market Size by Type
8.2.1 China Antivenin Sales Quantity by Type (2018-2034)
8.2.2 China Antivenin Revenue by Type (2018-2034)
8.3 China Antivenin Market Size by Application
8.3.1 China Antivenin Sales Quantity by Application (2018-2034)
8.3.2 China Antivenin Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Antivenin Sales by Company
9.1.1 APAC Antivenin Sales Quantity by Company (2018-2024)
9.1.2 APAC Antivenin Revenue by Company (2018-2024)
9.2 APAC Antivenin Market Size by Type
9.2.1 APAC Antivenin Sales Quantity by Type (2018-2034)
9.2.2 APAC Antivenin Revenue by Type (2018-2034)
9.3 APAC Antivenin Market Size by Application
9.3.1 APAC Antivenin Sales Quantity by Application (2018-2034)
9.3.2 APAC Antivenin Revenue by Application (2018-2034)
9.4 APAC Antivenin Market Size by Region
9.4.1 APAC Antivenin Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Antivenin Revenue by Region (2018-2034)
9.4.3 APAC Antivenin Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antivenin Sales by Company
10.1.1 Middle East, Africa and Latin America Antivenin Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Antivenin Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Antivenin Market Size by Type
10.2.1 Middle East, Africa and Latin America Antivenin Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Antivenin Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Antivenin Market Size by Application
10.3.1 Middle East, Africa and Latin America Antivenin Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Antivenin Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Antivenin Market Size by Country
10.4.1 Middle East, Africa and Latin America Antivenin Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Antivenin Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Antivenin Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Information
11.1.2 CSL Overview
11.1.3 CSL Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 CSL Antivenin Products and Services
11.1.5 CSL Antivenin SWOT Analysis
11.1.6 CSL Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Antivenin Products and Services
11.2.5 Merck Antivenin SWOT Analysis
11.2.6 Merck Recent Developments
11.3 BTG
11.3.1 BTG Company Information
11.3.2 BTG Overview
11.3.3 BTG Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 BTG Antivenin Products and Services
11.3.5 BTG Antivenin SWOT Analysis
11.3.6 BTG Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Pfizer Antivenin Products and Services
11.4.5 Pfizer Antivenin SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Company Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Haffkine Bio-Pharmaceutical Antivenin Products and Services
11.5.5 Haffkine Bio-Pharmaceutical Antivenin SWOT Analysis
11.5.6 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Rare Disease Therapeutics
11.6.1 Rare Disease Therapeutics Company Information
11.6.2 Rare Disease Therapeutics Overview
11.6.3 Rare Disease Therapeutics Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Rare Disease Therapeutics Antivenin Products and Services
11.6.5 Rare Disease Therapeutics Antivenin SWOT Analysis
11.6.6 Rare Disease Therapeutics Recent Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Company Information
11.7.2 Flynn Pharma Overview
11.7.3 Flynn Pharma Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Flynn Pharma Antivenin Products and Services
11.7.5 Flynn Pharma Antivenin SWOT Analysis
11.7.6 Flynn Pharma Recent Developments
11.8 Vins Bioproducts
11.8.1 Vins Bioproducts Company Information
11.8.2 Vins Bioproducts Overview
11.8.3 Vins Bioproducts Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Vins Bioproducts Antivenin Products and Services
11.8.5 Vins Bioproducts Antivenin SWOT Analysis
11.8.6 Vins Bioproducts Recent Developments
11.9 Bharat Serums and Vaccines
11.9.1 Bharat Serums and Vaccines Company Information
11.9.2 Bharat Serums and Vaccines Overview
11.9.3 Bharat Serums and Vaccines Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Bharat Serums and Vaccines Antivenin Products and Services
11.9.5 Bharat Serums and Vaccines Antivenin SWOT Analysis
11.9.6 Bharat Serums and Vaccines Recent Developments
11.10 Serum Biotech
11.10.1 Serum Biotech Company Information
11.10.2 Serum Biotech Overview
11.10.3 Serum Biotech Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Serum Biotech Antivenin Products and Services
11.10.5 Serum Biotech Antivenin SWOT Analysis
11.10.6 Serum Biotech Recent Developments
11.11 MicroPharm
11.11.1 MicroPharm Company Information
11.11.2 MicroPharm Overview
11.11.3 MicroPharm Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 MicroPharm Antivenin Products and Services
11.11.5 MicroPharm Recent Developments
11.12 CSL
11.12.1 CSL Company Information
11.12.2 CSL Overview
11.12.3 CSL Antivenin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 CSL Antivenin Products and Services
11.12.5 CSL Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antivenin Value Chain Analysis
12.2 Antivenin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antivenin Production Mode & Process
12.4 Antivenin Sales and Marketing
12.4.1 Antivenin Sales Channels
12.4.2 Antivenin Distributors
12.5 Antivenin Customers
13 Market Dynamics
13.1 Antivenin Industry Trends
13.2 Antivenin Market Drivers
13.3 Antivenin Market Challenges
13.4 Antivenin Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antivenin Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Polyvalent
Table 3. Major Manufacturers of Monovalent
Table 4. Global Antivenin Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Antivenin Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Antivenin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Antivenin Revenue Market Share by Region (2018-2024)
Table 8. Global Antivenin Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Antivenin Revenue Market Share by Region (2024-2034)
Table 10. Global Antivenin Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Vials)
Table 11. Global Antivenin Sales by Region (2018-2024) & (K Vials)
Table 12. Global Antivenin Sales Market Share by Region (2018-2024)
Table 13. Global Antivenin Sales by Region (2024-2034) & (K Vials)
Table 14. Global Antivenin Sales Market Share by Region (2024-2034)
Table 15. Global Antivenin Sales Quantity by Manufacturers (2018-2024) & (K Vials)
Table 16. Global Antivenin Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Antivenin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Antivenin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Antivenin Price by Manufacturers 2018-2024 (USD/Vial)
Table 20. Global Key Players of Antivenin, Industry Ranking, 2021 VS 2022
Table 21. Global Antivenin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Antivenin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenin as of 2022)
Table 23. Global Key Manufacturers of Antivenin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Antivenin, Product Offered and Application
Table 25. Global Key Manufacturers of Antivenin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 28. Global Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 29. Global Antivenin Sales Quantity Share by Type (2018-2024)
Table 30. Global Antivenin Sales Quantity Share by Type (2024-2034)
Table 31. Global Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Antivenin Revenue Share by Type (2018-2024)
Table 34. Global Antivenin Revenue Share by Type (2024-2034)
Table 35. Antivenin Price by Type (2018-2024) & (USD/Vial)
Table 36. Global Antivenin Price Forecast by Type (2024-2034) & (USD/Vial)
Table 37. Global Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 38. Global Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 39. Global Antivenin Sales Quantity Share by Application (2018-2024)
Table 40. Global Antivenin Sales Quantity Share by Application (2024-2034)
Table 41. Global Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Antivenin Revenue Share by Application (2018-2024)
Table 44. Global Antivenin Revenue Share by Application (2024-2034)
Table 45. Antivenin Price by Application (2018-2024) & (USD/Vial)
Table 46. Global Antivenin Price Forecast by Application (2024-2034) & (USD/Vial)
Table 47. North America Antivenin Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Antivenin Sales Quantity by Company (2018-2024) & (K Vials)
Table 49. North America Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 50. North America Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 51. North America Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 54. North America Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 55. North America Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Antivenin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Antivenin Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Antivenin Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Antivenin Sales Quantity by Country (2018-2024) & (K Vials)
Table 61. North America Antivenin Sales Quantity by Country (2024-2034) & (K Vials)
Table 62. Europe Antivenin Sales Quantity by Company (2018-2024) & (K Vials)
Table 63. Europe Antivenin Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 65. Europe Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 66. Europe Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 69. Europe Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 70. Europe Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Antivenin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Antivenin Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Antivenin Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Antivenin Sales Quantity by Country (2018-2024) & (K Vials)
Table 76. Europe Antivenin Sales Quantity by Country (2024-2034) & (K Vials)
Table 77. China Antivenin Sales Quantity by Company (2018-2024) & (K Vials)
Table 78. China Antivenin Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 80. China Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 81. China Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 84. China Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 85. China Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Antivenin Sales Quantity by Company (2018-2024) & (K Vials)
Table 88. APAC Antivenin Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 90. APAC Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 91. APAC Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 94. APAC Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 95. APAC Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Antivenin Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Antivenin Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Antivenin Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Antivenin Sales Quantity by Region (2018-2024) & (K Vials)
Table 101. APAC Antivenin Sales Quantity by Region (2024-2034) & (K Vials)
Table 102. Middle East, Africa and Latin America Antivenin Sales Quantity by Company (2018-2024) & (K Vials)
Table 103. Middle East, Africa and Latin America Antivenin Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antivenin Sales Quantity by Type (2018-2024) & (K Vials)
Table 105. Middle East, Africa and Latin America Antivenin Sales Quantity by Type (2024-2034) & (K Vials)
Table 106. Middle East, Africa and Latin America Antivenin Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antivenin Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Antivenin Sales Quantity by Application (2018-2024) & (K Vials)
Table 109. Middle East, Africa and Latin America Antivenin Sales Quantity by Application (2024-2034) & (K Vials)
Table 110. Middle East, Africa and Latin America Antivenin Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Antivenin Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Antivenin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Antivenin Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Antivenin Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Antivenin Sales Quantity by Country (2018-2024) & (K Vials)
Table 116. Middle East, Africa and Latin America Antivenin Sales Quantity by Country (2024-2034) & (K Vials)
Table 117. CSL Company Information
Table 118. CSL Description and Overview
Table 119. CSL Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 120. CSL Antivenin Product and Services
Table 121. CSL Antivenin SWOT Analysis
Table 122. CSL Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Overview
Table 125. Merck Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 126. Merck Antivenin Product and Services
Table 127. Merck Antivenin SWOT Analysis
Table 128. Merck Recent Developments
Table 129. BTG Company Information
Table 130. BTG Description and Overview
Table 131. BTG Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 132. BTG Antivenin Product and Services
Table 133. BTG Antivenin SWOT Analysis
Table 134. BTG Recent Developments
Table 135. Pfizer Company Information
Table 136. Pfizer Description and Overview
Table 137. Pfizer Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 138. Pfizer Antivenin Product and Services
Table 139. Pfizer Antivenin SWOT Analysis
Table 140. Pfizer Recent Developments
Table 141. Haffkine Bio-Pharmaceutical Company Information
Table 142. Haffkine Bio-Pharmaceutical Description and Overview
Table 143. Haffkine Bio-Pharmaceutical Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 144. Haffkine Bio-Pharmaceutical Antivenin Product and Services
Table 145. Haffkine Bio-Pharmaceutical Antivenin SWOT Analysis
Table 146. Haffkine Bio-Pharmaceutical Recent Developments
Table 147. Rare Disease Therapeutics Company Information
Table 148. Rare Disease Therapeutics Description and Overview
Table 149. Rare Disease Therapeutics Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 150. Rare Disease Therapeutics Antivenin Product and Services
Table 151. Rare Disease Therapeutics Antivenin SWOT Analysis
Table 152. Rare Disease Therapeutics Recent Developments
Table 153. Flynn Pharma Company Information
Table 154. Flynn Pharma Description and Overview
Table 155. Flynn Pharma Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 156. Flynn Pharma Antivenin Product and Services
Table 157. Flynn Pharma Antivenin SWOT Analysis
Table 158. Flynn Pharma Recent Developments
Table 159. Vins Bioproducts Company Information
Table 160. Vins Bioproducts Description and Overview
Table 161. Vins Bioproducts Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 162. Vins Bioproducts Antivenin Product and Services
Table 163. Vins Bioproducts Antivenin SWOT Analysis
Table 164. Vins Bioproducts Recent Developments
Table 165. Bharat Serums and Vaccines Company Information
Table 166. Bharat Serums and Vaccines Description and Overview
Table 167. Bharat Serums and Vaccines Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 168. Bharat Serums and Vaccines Antivenin Product and Services
Table 169. Bharat Serums and Vaccines Antivenin SWOT Analysis
Table 170. Bharat Serums and Vaccines Recent Developments
Table 171. Serum Biotech Company Information
Table 172. Serum Biotech Description and Overview
Table 173. Serum Biotech Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 174. Serum Biotech Antivenin Product and Services
Table 175. Serum Biotech Antivenin SWOT Analysis
Table 176. Serum Biotech Recent Developments
Table 177. MicroPharm Company Information
Table 178. MicroPharm Description and Overview
Table 179. MicroPharm Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 180. MicroPharm Antivenin Product and Services
Table 181. MicroPharm Recent Developments
Table 182. CSL Company Information
Table 183. CSL Description and Overview
Table 184. CSL Antivenin Sales Quantity (K Vials), Revenue (US$ Million), Average Selling Price (ASP) (USD/Vial) and Gross Margin (2018-2024)
Table 185. CSL Antivenin Product and Services
Table 186. CSL Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Antivenin Distributors List
Table 190. Antivenin Customers List
Table 191. Antivenin Market Trends
Table 192. Antivenin Market Drivers
Table 193. Antivenin Market Challenges
Table 194. Antivenin Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenin Product Picture
Figure 2. Global Antivenin Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antivenin Market Share by Type in 2022 & 2034
Figure 4. Polyvalent Product Picture
Figure 5. Monovalent Product Picture
Figure 6. Global Antivenin Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Antivenin Market Share by Application in 2022 & 2034
Figure 8. Hospitals and Clinics
Figure 9. Non-profit Institutions
Figure 10. Antivenin Report Years Considered
Figure 11. Global Antivenin Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Antivenin Revenue 2018-2034 (US$ Million)
Figure 13. Global Antivenin Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Antivenin Sales Quantity 2018-2034 (K Vials)
Figure 15. Global Antivenin Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Antivenin Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Antivenin Sales Quantity YoY (2018-2034) & (K Vials)
Figure 18. North America Antivenin Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Antivenin Sales Quantity YoY (2018-2034) & (K Vials)
Figure 20. Europe Antivenin Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Antivenin Sales Quantity YoY (2018-2034) & (K Vials)
Figure 22. China Antivenin Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Antivenin Sales Quantity YoY (2018-2034) & (K Vials)
Figure 24. APAC Antivenin Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Antivenin Sales Quantity YoY (2018-2034) & (K Vials)
Figure 26. Middle East, Africa and Latin America Antivenin Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Antivenin Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Antivenin Revenue in 2022
Figure 29. Antivenin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Antivenin Revenue Market Share by Type (2018-2034)
Figure 32. Global Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Antivenin Revenue Market Share by Application (2018-2034)
Figure 34. North America Antivenin Revenue Market Share by Company in 2022
Figure 35. North America Antivenin Sales Quantity Market Share by Company in 2022
Figure 36. North America Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Antivenin Revenue Market Share by Type (2018-2034)
Figure 38. North America Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Antivenin Revenue Market Share by Application (2018-2034)
Figure 40. North America Antivenin Revenue Share by Country (2018-2034)
Figure 41. North America Antivenin Sales Quantity Share by Country (2018-2034)
Figure 42. United States Antivenin Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Antivenin Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Antivenin Sales Quantity Market Share by Company in 2022
Figure 45. Europe Antivenin Revenue Market Share by Company in 2022
Figure 46. Europe Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Antivenin Revenue Market Share by Type (2018-2034)
Figure 48. Europe Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Antivenin Revenue Market Share by Application (2018-2034)
Figure 50. Europe Antivenin Revenue Share by Country (2018-2034)
Figure 51. Europe Antivenin Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Antivenin Revenue (2018-2034) & (US$ Million)
Figure 53. France Antivenin Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Antivenin Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Antivenin Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Antivenin Revenue (2018-2034) & (US$ Million)
Figure 57. China Antivenin Sales Quantity Market Share by Company in 2022
Figure 58. China Antivenin Revenue Market Share by Company in 2022
Figure 59. China Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Antivenin Revenue Market Share by Type (2018-2034)
Figure 61. China Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Antivenin Revenue Market Share by Application (2018-2034)
Figure 63. APAC Antivenin Sales Quantity Market Share by Company in 2022
Figure 64. APAC Antivenin Revenue Market Share by Company in 2022
Figure 65. APAC Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Antivenin Revenue Market Share by Type (2018-2034)
Figure 67. APAC Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Antivenin Revenue Market Share by Application (2018-2034)
Figure 69. APAC Antivenin Revenue Share by Region (2018-2034)
Figure 70. APAC Antivenin Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Antivenin Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Antivenin Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Antivenin Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Antivenin Revenue (2018-2034) & (US$ Million)
Figure 75. India Antivenin Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Antivenin Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Antivenin Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Antivenin Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Antivenin Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Antivenin Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Antivenin Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Antivenin Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Antivenin Revenue Share by Country (2018-2034)
Figure 84. Brazil Antivenin Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Antivenin Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Antivenin Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Antivenin Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Antivenin Revenue (2018-2034) & (US$ Million)
Figure 89. Antivenin Value Chain
Figure 90. Antivenin Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed